Global Financial Private Client’s VanEck Pharmaceutical ETF PPH Stock Holding History

Global Financial Private Client’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1	Closed	-$91	–	1245
2025 Q1	$91	Hold	1	–	–	﹤0.01%	1614
2024 Q4	$86	Hold	1	–	–	﹤0.01%	1511
2024 Q3	$95	Hold	1	–	–	﹤0.01%	803
2024 Q2	$91	Hold	1	–	–	﹤0.01%	677
2024 Q1	$89	Hold	1	–	–	﹤0.01%	697
2023 Q4	$81	Hold	1	–	–	﹤0.01%	684
2023 Q3	$79	Hold	1	–	–	﹤0.01%	677
2023 Q2	$78	Hold	1	–	–	﹤0.01%	665
2023 Q1	$78	Hold	1	–	–	﹤0.01%	681
2022 Q4	$78	Sell	1 -50	-98%	-$3.69K	﹤0.01%	672
2022 Q3	$3.47K	Sell	51 -2,436	-98%	-$179K	﹤0.01%	493
2022 Q2	$192K	Buy	+2,487	New	+$194K	0.11%	138

Other funds holding PPH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return

JSAM

J. Safra Asset Management New York $1.86B AUM 22.95% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AWC

Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

Global Financial Private Client's PPH Position: Q2 2025 in Review

Global Financial Private Client sold out of VanEck Pharmaceutical ETF (PPH) in Q2 2025, closing a stake of 1 share — an estimated $91 sold.

Global Financial Private Client first reported a position in PPH in Q2 2022 and held it in 12 quarters. The position peaked at $192K in Q2 2022. 129 funds tracked by Wall St. Rank hold PPH as of Q2 2025.

Global Financial Private Client reported no remaining VanEck Pharmaceutical ETF position as of Q2 2025 after selling out during the quarter.
Global Financial Private Client sold 1 VanEck Pharmaceutical ETF share in Q2 2025, an estimated $91.
Global Financial Private Client first reported a position in VanEck Pharmaceutical ETF in Q2 2022 and held it in 12 quarters.
Global Financial Private Client's VanEck Pharmaceutical ETF position peaked at $192K in Q2 2022.
129 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2025.

Based on Global Financial Private Client's 13F filing for Q2 2025, filed 10 Jul 2025.